Ha-Jung Ryu
National Institutes of Health
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Ha-Jung Ryu.
Osteoporosis International | 2006
Joo-Yeon Hwang; Jong-Keuk Lee; Miey Park; Kyung-Seon Kim; Kwang-Joong Kim; Ha-Jung Ryu; Jeewoo Lee; Bok-Ghee Han; Jae-Jung Kim; Bermseok Oh; Kuchan Kimm; Byeong-Bae Park; Hyoung Doo Shin; Tae-Ho Kim; Jung-Min Hong; Eui Kyun Park; Dae-Yeon Kim; Jung-Min Koh; Ghi-Su Kim; Shin-Yoon Kim
IntroductionPlexin A2 (PLXNA2) is a receptor that recognizes secreted or membrane-bound semaphorin 3A, which is implicated in neural regulation of bone metabolism.Materials and MethodsIn the present study, we identified 48 genetic polymorphisms in PLXNA2 by resequencing, and 10 single nucleotide polymorphisms (SNPs) were selected for further investigation into their potential involvement in osteoporosis in a postmenopausal population (n=560).ResultsTwo SNPs, +14G>A (Gln5Arg) and +183429C>T (Tyr1621Tyr), and Block1-ht2 were associated with risk of vertebral fracture (p=0.01–0.05), and three SNPs, +799G>A (Ala267Thr), +135391G>A, and +190531G>C, were associated with bone mineral density at various femur sites (p=0.003–0.03). Particularly, the minor allele of +14G>A was associated with a protective effect on vertebral fracture and higher lumbar bone mineral density, suggesting that +14G>A may be a useful marker for osteoporosis and its related fracture.ConclusionThese results provide, for the first time, evidence supporting the association of PLXNA2 with osteoporosis in postmenopausal women.
Journal of Human Genetics | 2006
Hyun Sub Cheong; Hyoung Doo Shin; Soo Ok Lee; Byung Lae Park; Yoo Hyun Choi; Gun Il Lim; Soo Taek Uh; Young Hun Kim; Jong-Young Lee; Jong-Keuk Lee; Hung Tae Kim; Ha-Jung Ryu; Ka-Kyung Kim; Bok Ghee Han; Jun Woo Kim; Kuchan Kimm; Bermseok Oh; Choon-Sik Park
AbstractAirway inflammation is a major factor in the pathogenesis of asthma. Interleukin 8 (IL8) is a potent proinflammatory cytokine that interacts with its receptors, IL8RA and IL8RB. We investigated the genetic polymorphisms in IL8, IL8RA, and IL8RB for any association with risk of asthma and peripheral blood eosinophil counts in a Korean population. By carrying out direct sequencing in 24 individuals, we identified 20 sequence variants within exons and their flanking regions, including the 1.5 kb promoter regions of IL8, IL8RA, and IL8RB. Among them, seven common single-nucleotide polymorphisms (SNPs) were selected for genotyping in our asthma cohort (n = 1,439). Two common haplotypes in IL8 and three in IL8RA and IL8RB (defined as one block) were identified. Although none of the polymorphisms showed a significant association with risk of asthma, IL8RA-B ht2 showed a significant association with the peripheral blood eosinophil counts (%) among asthma patients, e.g., lower eosinophil levels among individuals with the homozygous IL8RA-B ht2 (3.55 ± 3.39%) than among other asthmatic patients (5.52 ± 5.55%; Pcorr = 0.018). Our findings suggest that polymorphisms and haplotypes in IL8RA and IL8RB might be among the genetic factors underlying production of peripheral blood eosinophil.
Immunogenetics | 2005
JuYoung Kim; Song-Mean Moon; Ha-Jung Ryu; Jae-Jung Kim; Hung-Tae Kim; Chan Park; Kuchan Kimm; Bermseok Oh; Jong-Keuk Lee
The tumor necrosis factor and TNF receptor (TNF–TNFR) superfamily plays very important roles in the pathogenesis of many immune-mediated diseases. Regulation of TNF–TNFR superfamily gene expression influences many aspects of the pathology associated with these diseases. In order to investigate genetic variations in the regulatory regions of the TNF–TNFR superfamily genes, promoter regions were screened by sequencing DNA samples from 24 unrelated Korean individuals. We identified a total of 68 single-nucleotide polymorphisms (SNPs) in the regulatory regions of the known TNF–TNFR superfamily genes, including 50 SNPs in the promoter regions, 16 SNPs in the 5′-UTR regions, and two SNPs in the coding regions of these genes. Among the 68 SNPs identified in this study, 25 SNPs were novel SNPs. Interestingly, the sequence alteration created by 11 SNPs completely abolished putative transcription factor binding sites in these alleles. These results suggest that these SNP sites can regulate gene expression by controlling the binding of transcription factors. The identification of function-altering SNPs in the promoter regions of the TNF–TNFR superfamily will facilitate efforts to understand the association of TNF–TNFR superfamily genes with several immune-mediated human diseases.
Experimental and Molecular Medicine | 2006
Soo-Cheon Chae; Byung Lae Park; Choon-Sik Park; Ha-Jung Ryu; Yun-Sik Yang; Soo Ok Lee; Yoo Hyun Choi; Eun Mi Kim; Soo Taek Uh; Young-Hoon Kim; Ka-Kyung Kim; Bermseok Oh; Hun-Taeg Chung; Kuchan Kimm; Hyoung Doo Shin
RUNX1, a member of the runt domain gene family of transcription factors, encodes a heterodimeric transcription factor and regulates the expression of various genes related to hematopoiesis and myeloid differentiation. RUNX1 has been one of the target genes for research into various autoimmune diseases due to its properties as a transcription factor and functional distribution for chromosomal translocation. In an effort to identify additional gene polymorphisms in which variants have been implicated in asthma, we investigated the genetic polymorphisms in RUNX1 to evaluate it as a potential candidate gene for a host genetic study of asthma and IgE production. We identified 19 sequence variants by direct DNA sequencing in 24 individuals of which four common variants were selected for genotyping in our asthma cohort (1,055 asthmatic patients, 384 normal controls). Using logistic regression analysis for association with the risk of asthma, while controlling for age, gender, and smoking status as covariates, no significant associations with the risk of asthma were detected. However, two polymorphisms in the promoter region (-2084G>C and -1282G>A) showed a marginal association with total IgE levels (0.03 and 0.03 in recessive models, respectively). Our findings suggest that polymorphisms in RUNX1 might be one of the genetic factors for the regulation of IgE production.
Journal of Hypertension | 2007
Seung-Hun Cha; Hung-Tae Kim; Yangsoo Jang; Sungha Park; Jae-Jung Kim; Min Young Song; Jin-Hyoung Park; Ha-Jung Ryu; Hyun-Young Park; Sungjoo Kim Yoon; Kuchan Kimm; Jong-Keuk Lee; Bermseok Oh
Objective Coronary artery disease is caused by multiple genetic and environmental factors. The disease is also closely associated with cardiovascular conditions such as hypertension. In order to investigate any possible role of hypertension candidate genes in the disease development and progression, we examined the association of the polymorphisms of 31 hypertension candidate genes with coronary artery disease. Methods Genetic polymorphisms of 31 hypertension candidate genes were initially screened by resequencing DNA samples from 24 unrelated individuals in a Korean population. Association analysis was performed using 1284 unrelated Korean men, including 749 coronary artery disease subjects and 535 normal healthy controls. Results We identified a total of 409 single nucleotide polymorphisms including 40 nonsynonymous single nucleotide polymorphisms, 32 insertions/deletions and four microsatellites. Among 40 nonsynonymous single nucleotide polymorphisms, 29 were examined for an association with coronary artery disease. A significant association with coronary artery disease was observed in a polymorphism of the ADD1 gene (Gly460Trp; +29017G/T) (odds ratio 0.71–0.81; P = 0.01–0.04). The same polymorphism was also associated with the number of arteries with significant coronary artery stenosis in the coronary artery disease patients (P = 0.01) as well as the increase in systolic blood pressure (P = 0.02). Conclusions The ADD1 Gly460Trp polymorphism is significantly associated with an increased risk of coronary artery disease as well as blood pressure, indicating that ADD1 plays a role in the pathogenesis of coronary artery disease as well as hypertension.
Diabetes Research and Clinical Practice | 2009
Kyung-Won Hong; Hyun-Seok Jin; Ji-Eun Lim; Ha-Jung Ryu; Min Jin Go; Jong-Young Lee; Jeong-Taek Woo; Hun Kuk Park; Bermseok Oh
Under the activation of insulin receptors, glucose transporter 4 (Glut4) translocation is regulated by two signal transduction pathways. These pathways are the PI 3-kinase-dependent pathway and the CAP/TC10 pathway. The adaptor protein Rap guanine exchange factor 1 (RAPGEF1) also known as C3G is a component of the CAP/TC10 pathway. Defects in the RAPGEF1 protein may contribute to insulin resistance and type 2 diabetes. Recently, the RAPGEF1 gene was suggested to be involved in the development of type 2 diabetes by FUSION study. To investigate this association in the Korean population, we sequenced the RAPGEF1 gene in 24 unrelated individuals and identified 39 sequence variants. Eleven single nucleotide polymorphisms (SNPs) were selected and genotyped in 1122 Korean patients with type 2 diabetes. There were 1138 non-diabetic controls. Using a logistic regression analysis, a significant association was found between SNP rs11243444 in the RAPGEF1 gene and type 2 diabetes [OR=0.490 (95% CI 0.296-0.813), p=0.006] in the recessive model, leading the protective effect of the GG genotype on the disease development. The present study examines genetic polymorphisms in the RAPGEF1 gene, and the positive association between one polymorphism and type 2 diabetes in the Korean population.
International Archives of Allergy and Immunology | 2006
Ha-Jung Ryu; Ho-Youl Jung; Jung-Sun Park; Gil-Mi Ryu; Jee Yeon Heo; Jae-Jung Kim; Song-Mean Moon; Hung-Tae Kim; Jong-Young Lee; InSong Koh; Jun-Woo Kim; Jae Kyun Rho; Bok-Ghee Han; Hyungtae Kim; Choon-Sik Park; Bermseok Oh; Chan Park; Jong-Keuk Lee; Kuchan Kimm
Background and Methods: Numerous genetic studies have mapped asthma susceptibility genes to a region on chromosome 5q31–33 in several populations. This region contains a cluster of cytokines and other immune-related genes important in immune response. In the present study, to determine the genetic variations and patterns of linkage disequilibrium (LD), we resequenced all the exons and promoter regions of the 29 asthma candidate genes in the chromosome 5q31–33 region. Results: We identified a total of 314 genetic variants, including 289 single nucleotide polymorphisms (SNPs), 22 insertion/deletion polymorphisms and 3 microsatellites. Standardized variance data for allele frequency revealed substantial differences in SNP allele frequencies among different ethnic groups. Interestingly, significant ethnic differences were observed mainly in intron SNPs. LD block analysis using 174 common SNPs with a frequency of >10% disclosed strong LD within most candidate genes. No significant LD was observed across genes, except for one LD block (CD14-IK block). Gene-based haplotype analyses showed that 1–5 haplotype-tagging SNPs may be used to define the six or fewer common haplotypes with a frequency of >5%, regardless of the number of SNPs. Conclusion: Overall, our results provide useful information for the identification of immune-mediated disease genes in the chromosome 5q31–33 region, as well as valuable evidence for gene-based haplotype analysis in disease association studies.
Immunogenetics | 2005
Jae-Jung Kim; Hyun-Hee Kim; Joo-Hyun Park; Ha-Jung Ryu; JuYoung Kim; Song-Mean Moon; Haeok Gu; Hung-Tae Kim; Jong-Young Lee; Bok-Ghee Han; Chan Park; Kuchan Kimm; Choon-Sik Park; Jong-Keuk Lee; Bermseok Oh
Asthma is a chronic inflammatory disorder of the airways, and a number of genetic loci are associated with the disease. Candidate gene association studies have been regarded as effective tools to study complex traits. Knowledge of the sequence variation and structure of the candidate genes is required for association studies. Thus, we investigated the genetic variants of 32 asthma candidate genes selected by colocalization of positional and functional candidate genes. We screened all exons and promoter regions of those genes using 12 healthy individuals and 12 asthma patients and identified a total of 418 single nucleotide polymorphisms (SNPs), including 270 known SNPs and 148 novel SNPs. Levels of nucleotide diversity varied from gene to gene (0.72×10−4–14.53×10−4), but the average nucleotide diversity between coding SNPs (cSNPs) and noncoding SNPs was roughly equivalent (4.63×10−4 vs 4.69×10−4). However, nucleotide diversity of cSNPs was strongly correlated to codon degeneracy. Nucleotide diversity was much higher at fourfold degenerate sites than at nondegenerate sites (9.42×10−4 vs 3.14×10−4). Gene-based haplotype analysis of asthma-associated genes in this study revealed that common haplotypes (frequency >5%) represented 90.5% of chromosomes, and they could be uniquely identified with five or fewer haplotype-tagging SNPs per gene. Therefore, our results may have important implications for the selection of asthma candidate genes and SNP markers for comprehensive association studies using large sample populations.
Genomics & Informatics | 2008
Kyung-Won Hong; Hyun-Seok Jin; Ji-Eun Lim; Ha-Jung Ryu; Younjhin Ahn; Jong-Young Lee; Bok-Ghee Han; Hyoung Doo Shin; N. H. Cho; Chol Shin; Jeong-Taek Woo; Hun-Kuk Park; Bermseok Oh
Protein phosphorylation at tyrosine residues is a key regulatory event that modulates insulin signal transduction. We studied the PTPN1 gene with regard to susceptibility to Korean type 2 diabetes mellitus (T2DM) and its related quantitative t raits. A total of seven SNPs [g.36171G>A (rs941798), g.58166G>A (rs3787343), g.58208A>G (rs2909270), g.64840C>T (rs754118), g.69560C>G (rs6020612), g.69866G>A (rs718050), and g.69934T>G (rs3787343)] were selected based on frequency (>0.05), linkage disequilibrium (LD) status, and haplotype tagging status. We studied the seven SNPs in 483 unrelated patients with type 2 diabetes (age: 64±2.8 years, onset age: 56±8.1 years; 206 men, 277 women) and 1138 nondiabetic control subjects (age: 64±2.9; 516 men, 622 women). The SNP rs941798 had protective effects against T2DM with an odds ratio of 0.726 (C.I. 0.541∼0.975) and p-value=0.034, but none of the remaining six SNPs was associated with T2DM. Also, rs941798 was associated with blood pressure, HDL cholesterol, insulin sensitivity. rs941798 also has been associated with T2DM in previous reports of Caucasian-American and Hispanic-American populations. This is the first report that shows an association between PTPN1 and T2DM in the Korean as well as Asian population.
Genomics & Informatics | 2008
Ha-Jung Ryu; Youngjoo Kim; Young-Kyu Park; Jae-Jung Kim; Mi-Young Park; Eul-Ju Seo; Han-Wook Yoo; In-Sook Park; Bermseok Oh; Jong-Keuk Lee
Abstract The human genome has evolved as a consequence of evolutionary forces, such as natural selection. In this study, we investigated natural selection on the human genes by comparing the numbers of nonsynonymous (NS) and synonymous (S) mutations in individual genes. We initially collected all coding SNP data of all human genes from the public dbSNP. Among the human genes, we selected 3 different selection groups of genes: pos-itively selected genes (NS/S≥3), negatively selected genes (NS/S≤1/3) and neutral selection genes (0.9 <NS/S<1.1). We characterized human genes targeted by natural selection. Negatively selected human genes were markedly associated with disease occurrence, but not positively selected genes. Interestingly, positively se-lected genes displayed an increase in potentially delete-rious nonsynonymous SNPs with an increased fre-quency of tryptophan and tyrosine residues, suggesting a correlation with protective effects against human disease. Furthermore, our nonsynonymous/synonymous ratio data imply that specific human genes, such as ALMS1 and SPTBN5 genes, are differentially selected among distinct populations. We confirmed that in-ferences of natural selection using the NS/S ratio can be used extensively to identify functional genes selected during the evolutionary adaptation process.Keywords: single nucleotide polymorphism (SNP), natu-ral selection, disease genes, ethnicity